Skip to content

Epigenetic Effects in Children With Cow's Milk Allergy Treated With Different Formulas

Epigenetic Effects Involved in Children With Cow's Milk Allergy: A Possible Effect of Hypoallergenic Formulas

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04184700
Acronym
EPICMA II
Enrollment
90
Registered
2019-12-03
Start date
2019-12-10
Completion date
2024-08-31
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cow Milk Allergy

Brief summary

Lactobacillus GG (LGG) is able to exert long lasting effects in children with atopic disorders. Nutramigen LGG accelerates tolerance acquisition in infants with cow's milk allergy. The mechanisms of these effects are still largely undefined. The effect of LGG could be related at least in part by the immunoregulatory role played by LGG. This probiotic can balance the generation of cytokines possibly involved in IgE- or non-IgE-mediated cow's milk allergy Interleulkin (IL)-4, IL-5, IL-10, IFN-γ , TGF-β, and TNF-Υ), which can contribute to modulation of inflammatory processes. The investigators have demonstrated that children with IgE-mediated CMA produce significantly higher level of IL-4 and IL-13 in response to cow's milk protein, and that tolerance is associated with a marked reduction of IL-13 production and a concomitant increased frequency of IFN-γ releasing cells. Epigenetics studies the heritable (and potentially reversible) changes of the genome inherited from one cell generation to the next which alter gene expression but do not involve changes in primary DNA sequences, highlighting the complexity of the inter-relationship between genetics and nutrition. There are three distinct, but closely interacting, epigenetic mechanisms (histone acetylation, DNA methylation, and non-coding microRNAs) that are responsible for modifying the expression of critical genes associated with physiologic and pathologic processes. The profile of epigenetic modifications associated with Th lineage commitment, coupled with the sensitivity of the early developmental period, has led to speculation that factors that disrupt these pathways may increase the risk of allergic diseases. Specifically, effects on DNA methylation and endogenous histone deacetylase inhibitors acting on specific pathways (Th1 and T regulatory cell differentiation) may favour Th2-associated allergic differentiation. MicroRNAs are another structural components of an epigenetic mechanism of post-transcriptional regulation of messenger RNA translation. It has been recently identified a specific Th2-associated microRNA (miR-21) that is critical for the regulation of Th cell polarization. It has been previously demonstrated an inverse DNA methylation pattern of cytokines involved in Th2 response (IL-4, IL-5) compared with cytokines involved in Th1 response (IL-10, INF- y) in children with CMA acquiring oral tolerance, with the most pronounced effects in those treated with Nutramigen LGG.

Interventions

DIETARY_SUPPLEMENTEHCF+LGG

Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG

DIETARY_SUPPLEMENTRHF

Rice hydrolysed formula

DIETARY_SUPPLEMENTSF

Soy formula

DIETARY_SUPPLEMENTEHWF

extensively hydrolysed whey formula

DIETARY_SUPPLEMENTAAF

amino acid based formula

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Months to 12 Months
Healthy volunteers
No

Inclusion criteria

* children with cow's milk allergy

Exclusion criteria

* Concomitant chronic systemic diseases, * congenital cardiac defects, * active tuberculosis, * autoimmune diseases, * immunodeficiency, * chronic inflammatory bowel diseases, * celiac disease, * cystic fibrosis, * metabolic diseases, * malignancy, * chronic pulmonary diseases, * malformations of the gastrointestinal tract, * suspected eosinophilic esophagitis or eosinophilic enterocolitis, * suspected food-protein-induced enterocolitis syndrome, * suspected cow's milk protein-induced anaphylaxis, * still on exclusion diet with one of the study formulas or with another dietary regimen because of cow's milk allergy, * other food allergies.

Design outcomes

Primary

MeasureTime frameDescription
Epigenetic modifications in cytokines genes12 monthsTSDR demethylation (prop.) of FOXP3 in children with cow's milk allergy. The primary outcome was the time-averaged FoxP3 Treg-Specific-Demethylation-Region (TSDR) demethylation (prop.), which took into account three repeated measures (0,6,12 months).

Secondary

MeasureTime frameDescription
Epigenetic modifications in cytokines genes6 and 12 monthsDemethtylation rate and expression (fc, fold change, ΔΔCt method)) of FOXP3 in children with cow's milk allergy
microRNAs modifications12 monthsExpression of miR-125b miR-146a miR-155 miR-29a/b miR-27a miR-128 miR-21 miR-126 miR-145 miR-106a miR-193a5p miR-128
The rate of patients with immune tolerance acquisition to cow's milk protein12 monthsRate of patients with acquisition of tolerance to cow milk protein (rate of patients with outgrown cow's milk allergy)
Concentration of metagenomic characteristics of the intestinal microbiota12 monthsevaluation of composition of gut microbiota
Concentration of metabolomic characteristics of the intestinal microbiota12 monthsevaluation of function of gut microbiota

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026